Cisplatin, Capecitabine, Gemcitabine and Epirubicin or Docetaxel for Patients With Stage III or IV Pancreatic Cancer
Clinical trial NCT00966706 · COMPLETED
Trial details
- NCT number
- NCT00966706
- Sponsor
- IRCCS San Raffaele
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-06-01
- Primary completion
- 2009-04-01
- Enrollment
- 105
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.